Jo K. Perry

Dr. Jo K. Perry

Liggins Institute, University of Auckland, Auckland, New Zealand
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 1997 in Planta
Verified
Journal Article
Closed access
PDF file
RRRobert J. Redgwell
Robert J. Redgwell
EMElspeth MacRae
Elspeth MacRae
IHIan Hallett
Ian Hallett
MFMonica Fischer
Monica Fischer
Jo K. PerryJo K. Perry
Jo K. Perry
RHRoger Harker
Roger Harker

14 April 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DADavid Amor
David Amor
KBKaren Bentley
Karen Bentley
JRJacinta Ryan
Jacinta Ryan
Jo K. PerryJo K. Perry
Jo K. Perry
LWLee H. Wong
Lee H. Wong
KCK. H. Andy Choo
K. H. Andy Choo
Centromere repositioning provides a potentially powerful evolutionary force for reproductive isolation and speciation, but the underlying mechanisms remain ill-defined. An attractive model is through the simultaneous inactivation of a normal centromere and the formation of a new centromere at a hitherto noncentromeric chromosomal location with minimal detrimental effect. We report a two-generation family in which the centromeric activity of one chromosome 4 has been relocated to a euchromatic site at 4q21.3 through the epigenetic formation of a neocentromere in otherwise cytogenetically normal and mitotically stable karyotypes. Strong epigenetic inactivation of the original centromere is suggested by retention of 1.3 megabases of centromeric α-satellite DNA, absence of detectable molecular alteration in chromosome 4-centromereproximal p- and q-arm sequences, and failure of the inactive centromere to be reactivated through extensive culturing or treatment with histone deacetylase inhibitor trichostatin A. The neocentromere binds functionally essential centromere proteins (CENP-A, CENP-C, CENP-E, CENP-I, BUB1, and HP1), although a moderate reduction in CENP-A binding and sister-chromatid cohesion compared with the typical centromeres suggests possible underlying structural/functional differences. The stable mitotic and meiotic transmissibility of this pseudodicentric-neocentric chromosome in healthy individuals and the ability of the neocentric activity to form in a euchromatic site in preference to a preexisting alphoid domain provide direct evidence for an inherent mechanism of human centromere repositioning and karyotype evolution “in progress.” We discuss the wider implication of such a mechanism for meiotic drive and the evolution of primate and other species.

8 February 2019 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
MLMan Lu
Man Lu
JFJack U. Flanagan
Jack U. Flanagan
RLRies J. Langley
Ries J. Langley
MHMichael Hay
Michael Hay
Jo K. PerryJo K. Perry
Jo K. Perry
Human growth hormone (GH) is a classical pituitary endocrine hormone that is essential for normal postnatal growth and has pleiotropic effects across multiple physiological systems. GH is also expressed in extrapituitary tissues and has localized autocrine/paracrine effects at these sites. In adults, hypersecretion of GH causes acromegaly, and strategies that block the release of GH or that inhibit GH receptor (GHR) activation are the primary forms of medical therapy for this disease. Overproduction of GH has also been linked to cancer and the microvascular complications that are associated with diabetes. However, studies to investigate the therapeutic potential of GHR antagonism in these diseases have been limited, most likely due to difficulty in accessing therapeutic tools to study the pharmacology of the receptor in vivo. This review will discuss current and emerging strategies for antagonizing GH function and the potential disease indications.

1 November 2001 in Genome Research
Verified
Journal Article
Closed access
Jo K. PerryJo K. Perry
Jo K. Perry
SPSteve Palmer
Steve Palmer
AGAnastasia Gabriel
Anastasia Gabriel
AAAlan Ashworth
Alan Ashworth
The pseudoautosomal region (PAR) of mammalian sex chromosomes is a small region of sequence identity that is the site of an obligatory pairing and recombination event between the X and Y chromosomes during male meiosis. During female meiosis, X chromosomes can pair and recombine along their entire length; recombination in the PAR is therefore ∼10× greater in male meiosis compared with female meiosis. A consequence of the presence of the PAR in two copies in males and females is that genes in the region escape the process of X-inactivation. Although the structure and gene content of the human PAR at Xq/Yq is well understood, the mouse PAR, which appears to be of independent evolutionary origin, is poorly characterized. Here we describe a yeast artificial chromosome (YAC) contig covering the distal part of the mouse X chromosome, which we have used to define the pseudoautosomal boundary, that is, the point of divergence of X-specific and X-Y–identical sequences. In addition, we have investigated the size of the mouse PAR by integrating a unique restriction endonuclease recognition site just proximal to the pseudoautosomal boundary by homologous recombination. Restriction digestion of this modified DNA and pulsed field gel electrophoresis reveal that the PAR in these cells is ∼700 kb. Thus, the mouse PAR, although small in size, has retained essential sex chromosome pairing functions despite its rapid rate of evolution.

1 October 2006 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
Jo K. PerryJo K. Perry
Jo K. Perry
SBStarling Emerald Bright
Starling Emerald Bright
HMHichem C. Mertani
Hichem C. Mertani
PLPeter E. Lobie
Peter E. Lobie

1 March 2008 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
Jo K. PerryJo K. Perry
Jo K. Perry
Kannan NagarajanKannan Nagarajan
Kannan Nagarajan
PGPrudence M. Grandison
Prudence M. Grandison
MMMurray Mitchell
Murray Mitchell
PLPeter E. Lobie
Peter E. Lobie